Cases | Age/sex | Vascular risk factors | Initial clinical manifestations | Suzuki stage (initial DSA) | PCA-ACA (initial DSA) | PCA-MCA (initial DSA) | No of mons btwn initial to second DSA | Suzuki stage (second DSA) | PCA-ACA (initial DSA) | PCA-MCA (initial DSA) |
1 | 19/F | – | IVH | L(3)R(0) | L(2)R(1) | L(4)R(1) | 100 | L(3)R(1) | L(2)R(2) | L(4)R(3) |
2 | 35/F | HP | TIA | L(5)R(0) | L(2)R(1) | L(4)R(0) | 137 | L(5)R(5) | L(2)R(1) | L(4)R(1) |
3 | 10/F | – | TIA | L(3)R(4) | L(2)R(2) | L(1)R(3) | 29 | L(4)R(4) | L(2)R(2) | L(3)R(3) |
4 | 28/M | – | Stroke | L(2)R(0) | L(1)R(0) | L(1)R(0) | 4 | L(4)R(0) | L(1)R(0) | L(1)R(0) |
5 | 32/F | – | TIA | L(3)R(0) | L(0)R(0) | L(1)R(0) | 37 | L(4)R(0) | L(0)R(0) | L(1)R(0) |
ACA, anterior cerebral artery; DSA, digital subtraction angiography; F, female; HP, hypertension; IVH, intraventricular haemorrhage; M, male; MCA, middle cerebral artery; MMD, moyamoya disease; PCA, posterior cerebral artery; TIA, transient ischaemic attack.